🔎 Trials Near Me

Home › Drug Use and Addiction › NCT07529327

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

Recruiting

Evidence-based Intervention Enhancements to Reduce Language Delays and Disorders Among Children of Parents With Substance Use Disorders

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

1. Have a:

   1. Self-reported lifetime history of substance use disorder treatment and/or
   2. active substance use in the past year
2. Be providing care for/parenting a child at least 10% of the time who is:

   1. between the ages of 12-42 months
   2. English/Spanish bilingual or monolingual in English or Spanish
   3. exposed to a third language once a week or less
   4. not yet combining three or more words regularly
   5. has less than 150 words in their expressive vocabulary
3. Be able to provide consent for their target child to participate, or have a legal guardian provide consent for the child to participate
4. Be able to speak and understand English and/or Spanish
5. Be willing to attend groups once a week for six weeks at a participating site/group time
6. If assigned additional services, willing to attend Zoom meetings
7. Be 18 years of age or older

Exclusion Criteria:

-Only one caregiver per focal child can participate in the research study. Caregivers whose participating child already has another caregiver enrolled in the research study will not be eligible to participate.

About the study

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

What is being tested

Sponsor: University of Oregon · Participants: 244 · Started: Mar 10, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07529327

Locations in the U.S.

OregonPrevention Science Institute, Eugene

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.